Sankesh Abbhi - Net Worth and Insider Trading
Sankesh Abbhi Net Worth
The estimated net worth of Sankesh Abbhi is at least $515,399 dollars as of 2024-09-20. Sankesh Abbhi is the Director of Brainstorm Cell Therapeutics Inc and owns about 2,169,187 shares of Brainstorm Cell Therapeutics Inc (BCLI) stock worth over $515,399. Details can be seen in Sankesh Abbhi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sankesh Abbhi has not made any transactions after 2020-07-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sankesh Abbhi
Sankesh Abbhi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sankesh Abbhi owns 1 companies in total, including Brainstorm Cell Therapeutics Inc (BCLI) .
Click here to see the complete history of Sankesh Abbhi’s form 4 insider trades.
Insider Ownership Summary of Sankesh Abbhi
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCLI | Brainstorm Cell Therapeutics Inc | 2020-07-15 | director |
Sankesh Abbhi Latest Holdings Summary
Sankesh Abbhi currently owns a total of 1 stock. Sankesh Abbhi owns 2,169,187 shares of Brainstorm Cell Therapeutics Inc (BCLI) as of July 15, 2020, with a value of $515,399.
Latest Holdings of Sankesh Abbhi
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCLI | Brainstorm Cell Therapeutics Inc | 2020-07-15 | 2,169,187 | 0.24 | 515,399 |
Holding Weightings of Sankesh Abbhi
Sankesh Abbhi Form 4 Trading Tracker
According to the SEC Form 4 filings, Sankesh Abbhi has made a total of 1 transactions in Brainstorm Cell Therapeutics Inc (BCLI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Brainstorm Cell Therapeutics Inc is the acquisition of 46,779 shares on July 15, 2020, which cost Sankesh Abbhi around $607,659.
Insider Trading History of Sankesh Abbhi
- 1
Sankesh Abbhi Trading Performance
GuruFocus tracks the stock performance after each of Sankesh Abbhi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sankesh Abbhi is 18.16%. GuruFocus also compares Sankesh Abbhi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sankesh Abbhi within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sankesh Abbhi's insider trading performs compared to the benchmark.
Performance of Sankesh Abbhi
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.55 | | | | | |
| Relative Return to S&P 500(%) | -1.98 | | | | | |
Sankesh Abbhi Ownership Network
Sankesh Abbhi Owned Company Details
What does Brainstorm Cell Therapeutics Inc do?
Who are the key executives at Brainstorm Cell Therapeutics Inc?
Sankesh Abbhi is the director of Brainstorm Cell Therapeutics Inc. Other key executives at Brainstorm Cell Therapeutics Inc include Chief Executive Officer Chaim Lebovits , EVP & Head Global Clin Research Stacy Lindborg , and Chief Medical Officer Kirk Taylor .
Brainstorm Cell Therapeutics Inc (BCLI) Insider Trades Summary
Over the past 18 months, Sankesh Abbhi made no insider transaction in Brainstorm Cell Therapeutics Inc (BCLI). Other recent insider transactions involving Brainstorm Cell Therapeutics Inc (BCLI) include a net purchase of 566,372 shares made by Chaim Lebovits , a net sale of 63,000 shares made by , and a net purchase of 11,500 shares made by Stacy Lindborg .
In summary, during the past 3 months, insiders sold 63,000 shares of Brainstorm Cell Therapeutics Inc (BCLI) in total and bought 0 shares, with a net sale of 63,000 shares. During the past 18 months, 63,000 shares of Brainstorm Cell Therapeutics Inc (BCLI) were sold and 577,872 shares were bought by its insiders, resulting in a net purchase of 514,872 shares.
Brainstorm Cell Therapeutics Inc (BCLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Brainstorm Cell Therapeutics Inc Insider Transactions
Sankesh Abbhi Mailing Address
Above is the net worth, insider trading, and ownership report for Sankesh Abbhi. You might contact Sankesh Abbhi via mailing address: 3119 Ponce De Leon, Unit C, Coral Gables Fl 33134.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
